Clinical trials
Completed Autoimmune Diseases trials in France
Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.
43 trials match Source: ClinicalTrials.gov registrations
Trials started per year
By phase, 2000 to 2026.
| Category | Trials |
|---|---|
| 2006 | 1 |
| 2008 | 2 |
| 2009 | 2 |
| 2010 | 1 |
| 2011 | 3 |
| 2012 | 4 |
| 2013 | 3 |
| 2014 | 1 |
| 2015 | 1 |
| 2016 | 1 |
| 2017 | 3 |
| 2018 | 6 |
| 2019 | 2 |
| 2020 | 5 |
| 2021 | 5 |
| 2022 | 1 |
| 2023 | 1 |
Status
Trials by registry status. Select a bar to filter.
| Category | Trials |
|---|---|
| Completed | 43 |
Top lead sponsors
A sponsor with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Assistance Publique - Hôpitaux de Paris | 5 |
| Human Genome Sciences Inc., a GSK Company | 5 |
| University Hospital, Bordeaux | 3 |
| University Hospital, Lille | 3 |
| University Hospital, Brest | 2 |
| University Hospital, Montpellier | 2 |
| University Hospital, Strasbourg, France | 2 |
| Alpine Immune Sciences Inc, A Subsidiary of Vertex | 1 |
| Baxalta now part of Shire | 1 |
| Bristol-Myers Squibb | 1 |
Top conditions
MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Autoimmune Diseases | 43 |
| Lupus Erythematosus, Systemic | 14 |
| Immune System Diseases | 7 |
| Arthritis, Rheumatoid | 4 |
| Multiple Sclerosis | 3 |
| Primary Immunodeficiency Diseases | 3 |
| Scleroderma, Systemic | 3 |
| Sjogren's Syndrome | 3 |
| Arthritis | 2 |
| Autoimmune Diseases of the Nervous System | 2 |
Trials
Showing 1 to 25 of 43. Each trial links to its page on Pharma Observatory.
Recently changed trials
Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.
No changes to these trials in the last 7 days.
Go deeper on Pharma Observatory
Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.